- Record: found
- Abstract: found
- Article: found
Cemiplimab, a human monoclonal anti-PD-1, in patients (pts) with advanced or metastatic hepatocellular carcinoma (HCC): Data from an expansion cohort in a phase I study
M.J. Pishvaian ,
G.J. Weiss ,
G.S. Falchook ,
N. Yee ,
M. Gil-Martin ,
S. Shahda ,
V. Moreno ,
I. Brana ,
M. Crittenden ,
S. Formenti ,
R. Al-Rajabi ,
K.P. Papadopoulos ,
E. Stankevich ,
M. Feng ,
J. Li ,
M. Mathias ,
G. Kroog ,
I. Lowy ,
M.G. Fury
October 2018
October 2018
Read this article at
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.